| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JNEUROIM.2006.06.028 |
| P698 | PubMed publication ID | 16934337 |
| P50 | author | Michael Khalil | Q57021488 |
| Markus Reindl | Q37383284 | ||
| P2093 | author name string | Thomas Berger | |
| P433 | issue | 1-2 | |
| P921 | main subject | pathophysiology | Q1135939 |
| P304 | page(s) | 50-62 | |
| P577 | publication date | 2006-08-23 | |
| P1433 | published in | Journal of Neuroimmunology | Q15716691 |
| P1476 | title | Antibodies as biological markers for pathophysiological processes in MS. | |
| P478 | volume | 180 |
| Q34024209 | A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis |
| Q36707237 | Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis |
| Q34387874 | Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study |
| Q28262403 | Antibody biomarkers in CNS demyelinating diseases - a long and winding road |
| Q37400354 | B cell characterization and reactivity analysis in multiple sclerosis |
| Q34253359 | Categorization of multiple sclerosis relapse subtypes by B cell profiling in the blood |
| Q36956709 | Cellular approaches for stimulating CNS remyelination |
| Q37087965 | Characteristics of Devic's disease (neuromyelitis optica) in Mexico |
| Q35614751 | Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis. |
| Q45363596 | Detection of antibodies to the 20s proteasome by ELISA. |
| Q30598338 | Diagnostic biomarkers in multiple sclerosis. |
| Q36229219 | Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain |
| Q37778622 | Emerging concepts in autoimmune encephalomyelitis beyond the CD4/TH1 paradigm |
| Q33599648 | Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation |
| Q39352482 | Experimental Models of Autoimmune Demyelinating Diseases in Nonhuman Primates. |
| Q34835462 | Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach |
| Q59273778 | Immunohistochemistry |
| Q37165162 | Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease |
| Q37582663 | Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis? |
| Q36647124 | Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy |
| Q46390509 | Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA. |
| Q35206805 | Role of pathogens in multiple sclerosis |
| Q85174183 | The clinical course of EAE is reflected by the dynamics of the neuroantigen-specific T cell compartment in the blood |
| Q37857982 | The immunopathophysiology of multiple sclerosis |
| Q38001792 | The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy? |
| Q28293355 | The spectrum of MOG autoantibody-associated demyelinating diseases |
| Q36839969 | The spectrum of multiple sclerosis |
Search more.